Pharmacokinetics of long-acting preparations of antitubercular drugs in rodents

Active Awarded Last action

Contract number
75N93025F00001
Awardee
Awarding agency
Obligated
$830,604

Award facts

Contract value 100% obligated
$830,604.00 Current and potential, with all options
Completion date 79% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · EO 14398 $0

About this award

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 30, 2025, under the Preclinical Services for HIV Therapeutics IDIQ, with a ceiling value of $830,604, for pharmacokinetics research on long-acting antitubercular drug preparations in rodents.

The order is priced on a cost-plus-fixed-fee basis with no set-aside applied. Place of performance is Menlo Park, CA. Work concludes January 31, 2027.

Quick answers

Who was awarded contract 75N93025F00001?

75N93025F00001 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2025.

How much is contract 75N93025F00001 worth?

The government has obligated $830,604 on 75N93025F00001.

Is contract 75N93025F00001 an order under another contract?

Yes. 75N93025F00001 is a delivery order under 75N93021D00001, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.

Was contract 75N93025F00001 competed?

The extent of competition for 75N93025F00001 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award